HistCite - BS Blumberg

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
1301	4822 SHAFRITZ DA, LIEBERMAN HM THE MOLECULAR-BIOLOGY OF HEPATITIS-B VIRUS ANNUAL REVIEW OF MEDICINE. 1984; 35: 219-232	4	14	13	50
1302	6267 ROBINSON WS MOLECULAR EVENTS IN THE PATHOGENESIS OF HEPADNAVIRUS-ASSOCIATED HEPATOCELLULAR-CARCINOMA ANNUAL REVIEW OF MEDICINE. 1994; 45: 297-323	15	125	16	94
1303	221 ROSS JD, SYVERTON JT, TREADWELL PEJ CULTURAL CHARACTERIZATION OF ANIMAL CELLS ANNUAL REVIEW OF MICROBIOLOGY. 1962; 16: 141-&	0	10	2	408
1304	1454 SENCER DJ EMERGING DISEASES OF MAN AND ANIMALS ANNUAL REVIEW OF MICROBIOLOGY. 1971; 25: 465-&	0	3	8	117
1305	3403 ROBINSON WS GENOME OF HEPATITIS-B VIRUS ANNUAL REVIEW OF MICROBIOLOGY. 1977; 31: 357-377	32	96	45	99
1306	3840 PIKE RM LABORATORY-ASSOCIATED INFECTIONS - INCIDENCE, FATALITIES, CAUSES, AND PREVENTION ANNUAL REVIEW OF MICROBIOLOGY. 1979; 33: 41-66	0	75	3	197
1307	5894 SHERKER AH, MARION PL HEPADNAVIRUSES AND HEPATOCELLULAR-CARCINOMA ANNUAL REVIEW OF MICROBIOLOGY. 1991; 45: 475-508	2	45	23	191
1308	5614 FISHER EA, COATES PM, CORTNER JA GENE POLYMORPHISMS AND VARIABILITY OF HUMAN APOLIPOPROTEINS ANNUAL REVIEW OF NUTRITION. 1989; 9: 139-160	0	10	6	106
1309	6 DORFMAN A, MATHEWS MB THE PHYSIOLOGY OF CONNECTIVE TISSUE ANNUAL REVIEW OF PHYSIOLOGY. 1956; 18: 69-88	2	13	1	242
1310	90 MANWELL C COMPARATIVE PHYSIOLOGY - BLOOD PIGMENTS ANNUAL REVIEW OF PHYSIOLOGY. 1960; 22: 191-244	0	138	0	476
#	Date / Author / Journal	LCS	GCS	LCR	CR
1311	1021 MAGNAN C, BENOIST J BLOOD TYPE GROUPS OF FRENCH CANADIANS IN THE REGION OF SAGUENAY-LAC SAINT-JEAN ANTHROPOLOGIE. 1969; 73 (1-2): 49-76	0	3	1	24
1312	4066 CORRAIN C, CAPITANIO M HEMO-TYPOLOGICAL OBSERVATIONS ON KOULANGO (IVORY-COAST) ANTHROPOLOGIE. 1980; 84 (3): 448-454	1	1	1	11
1313	8055 Mahal LK Glycomics: Towards bioinformatic approaches to understanding glycosylation ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2008 JAN; 8 (1): 37-51	1	14	3	142
1314	4823 DIX D, COHEN P THE INCIDENCE OF FEMALE CANCERS - CORRELATIONS WITH ETIOLOGIC IMPLICATIONS ANTICANCER RESEARCH. 1984; 4 (3): 197-202	0	4	1	20
1315	5662 LIN TM, CHEN CJ, WU MM, YANG CS, CHEN JS, et al. HEPATITIS-B VIRUS MARKERS IN CHINESE TWINS ANTICANCER RESEARCH. 1989 MAY-JUN; 9 (3): 737-741	16	60	10	29
1316	6245 PASCALE RM, SIMILE MM, FEO F GENOMIC ABNORMALITIES IN HEPATOCARCINOGENESIS - IMPLICATIONS FOR A CHEMOPREVENTIVE STRATEGY ANTICANCER RESEARCH. 1993 SEP-OCT; 13 (5A): 1341-1356	3	31	4	191
1317	6441 ANGHILERI LJ IRON, INTRACELLULAR CALCIUM-ION, LIPID-PEROXIDATION AND CARCINO-GENESIS ANTICANCER RESEARCH. 1995 JUL-AUG; 15 (4): 1395-1400	3	13	5	84
1318	6702 Anghileri LJ, Thouvenot P Non-transferrin-bound iron and tumor cells ANTICANCER RESEARCH. 1997 JUL-AUG; 17 (4A): 2529-2533	1	4	4	25
1319	6785 Csatary LK, Telegdy L, Gergely P, Bodey B, Bakacs T Preliminary report of a controlled trial of MTH-68/B (TM) virus vaccine treatment in acute B and C hepatitis: A phase II study ANTICANCER RESEARCH. 1998 MAR-APR; 18 (2B): 1279-1282	1	7	2	31
1320	6885 Wang F, Elliott RL, Head JF Inhibitory effect of deferoxamine mesylate and low iron diet on the 13762NF rat mammary adenocarcinoma ANTICANCER RESEARCH. 1999 JAN-FEB; 19 (1A): 445-450	6	26	5	35
#	Date / Author / Journal	LCS	GCS	LCR	CR
1321	6886 Csatary LK, Schnabel R, Bakacs T Successful treatment of decompensated chronic viral hepatitis by bursal disease virus vaccine ANTICANCER RESEARCH. 1999 JAN-FEB; 19 (1B): 629-633	0	7	3	27
1322	7085 Anghileri LJ, Plenat F, Labouyrie E, Thouvenot P Iron-and aluminum-induced carcinogenesis ANTICANCER RESEARCH. 2000 SEP-OCT; 20 (5A): 3007-3012	0	8	2	32
1323	7163 Fernandez-Pol JA, Hamilton PD, Klos DJ Essential viral and cellular zinc and iron containing metalloproteins as targets for novel antiviral and anticancer agents: Implications for prevention and therapy of viral diseases and cancer ANTICANCER RESEARCH. 2001 MAR-APR; 21 (2A): 931-957	0	18	2	176
1324	7340 Geier D, Hebert B, Potti A Risk of primary non-hepatocellular malignancies in hereditary hemochromatosis ANTICANCER RESEARCH. 2002 NOV-DEC; 22 (6B): 3797-3799	3	11	9	22
1325	7518 Yasumoto E, Nakano K, Nakayachi T, Morshed SRM, Hashimoto K, et al. Cytotoxic activity of deferiprone, maltol and related hydroxyketones against human tumor cell lines ANTICANCER RESEARCH. 2004 MAR-APR; 24 (2B): 755-762	0	23	2	24
1326	3149 DENES AE, EBERT JW, BERQUIST KR, MURPHY BL, MAYNARD JE ANTIVIRAL EFFECTS OF VIRAZOLE IN CHRONIC HEPATITIS-B SURFACE ANTIGEN-SEROPOSITIVE CHIMPANZEES ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 1976; 10 (3): 571-572	1	6	5	11
1327	4824 HANTZ O, OOKA T, VITVITSKI L, PICHOUD C, TREPO C COMPARISON OF PROPERTIES OF WOODCHUCK HEPATITIS-VIRUS AND HUMAN HEPATITIS-B VIRUS ENDOGENOUS DNA-POLYMERASES ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 1984; 25 (2): 242-246	9	42	5	32
1328	5772 FOUREL I, HANTZ O, WATANABE KA, JACQUET C, CHOMEL B, et al. INHIBITORY EFFECTS OF 2'-FLUORINATED ARABINOSYL-PYRIMIDINE NUCLEOSIDES ON WOODCHUCK HEPATITIS-VIRUS REPLICATION IN CHRONICALLY INFECTED WOODCHUCKS ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 1990 MAR; 34 (3): 473-475	7	53	4	18
1329	5829 YOKOTA T, KONNO K, CHONAN E, MOCHIZUKI S, KOJIMA K, et al. COMPARATIVE ACTIVITIES OF SEVERAL NUCLEOSIDE ANALOGS AGAINST DUCK HEPATITIS-B VIRUS INVITRO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 1990 JUL; 34 (7): 1326-1330	6	58	5	24
1330	6731 Cullen JM, Smith SL, Davis MG, Dunn SE, Botteron C, et al. In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1- [2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucks ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 1997 OCT; 41 (10): 2076-2082	11	38	9	63
#	Date / Author / Journal	LCS	GCS	LCR	CR
1331	6732 Witcher JW, Boudinot FD, Baldwin BH, Ascenzi MA, Tennant BC, et al. Pharmacokinetics of 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl) uracil in woodchucks ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 1997 OCT; 41 (10): 2184-2187	3	14	2	20
1332	6742 Hantz O, Borel C, Trabaud C, Zoulim F, Dessolin J, et al. Selective inhibition of the duck hepatitis B virus by a new class of tetraazamacrocycles ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 1997 NOV; 41 (11): 2579-2581	2	12	2	26
1333	7346 Mehta A, Conyers B, Tyrrell DLJ, Walters KA, Tipples GA, et al. Structure-activity relationship of a new class of anti-hepatitis B virus agents ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2002 DEC; 46 (12): 4004-4008	6	12	10	23
1334	7372 Stuyver LJ, Whitaker T, McBrayer TR, Hernandez-Santiago BI, Lostia S, et al. Ribonucleoside analogue that blocks replication of bovine viral diarrhea and hepatitis C viruses in culture ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2003 JAN; 47 (1): 244-254	5	59	3	47
1335	7425 Givens MD, Dykstra CC, Brock KV, Stringfellow DA, Kumar A, et al. Detection of inhibition of bovine viral diarrhea virus by aromatic cationic molecules ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2003 JUL; 47 (7): 2223-2230	5	27	2	46
1336	7426 Buckwold VE, Wei JY, Wenzel-Mathers M, Russell J Synergistic in vitro interactions between alpha interferon and ribavirin against bovine viral diarrhea virus and yellow fever virus as surrogate models of hepatitis C virus replication ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2003 JUL; 47 (7): 2293-2298	5	20	3	41
1337	7501 Durantel D, Carrouee-Durantel S, Branza-Nichita N, Dwek RA, Zitzmann N Effects of interferon, ribavirin, and iminosugar derivatives on cells persistently infected with noncytopathic bovine viral diarrhea virus ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2004 FEB; 48 (2): 497-504	14	31	12	45
1338	7538 Mehta AS, Gu BH, Conyers B, Ouzounov S, Wang LJ, et al. alpha-galactosylceramide and novel synthetic glycolipids directly induce the innate host defense pathway and have direct activity against hepatitis B and C viruses ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2004 JUN; 48 (6): 2085-2090	3	10	6	24
1339	7539 Iyer RP, Roland A, Morrey JD, Mounir S, Korba B Phosphorothioate di-and trinucleotides as a novel class of anti-hepatitis B virus agents ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2004 JUN; 48 (6): 2199-2205	0	16	3	25
1340	8011 Dougherty AM, Guo H, Westby G, Liu YJ, Simsek E, et al. A substituted tetrahydro-tetrazolo-pyrimidine is a specific and novel inhibitor of hepatitis B virus surface antigen secretion ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2007 DEC; 51 (12): 4427-4437	1	5	8	64
#	Date / Author / Journal	LCS	GCS	LCR	CR
1341	8099 Woodhouse SD, Smith C, Michelet M, Branza-Nichita N, Hussey M, et al. Iminosugars in combination with interferon and ribavirin permanently eradicate noncytopathic bovine viral diarrhea virus from persistently infected cells ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2008 MAY; 52 (5): 1820-1828	1	2	11	28
1342	8117 Jenke ACW, Wilhelm AD, Orth V, Lipps HJ, Protzer U, et al. Long-term suppression of hepatitis B virus replication by short hairpin RNA expression using the scaffold/matrix attachment region-based replicating vector system pEPI-1 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2008 JUL; 52 (7): 2355-2359	0	4	1	26
1343	8215 Chang JH, Wang LJ, Ma DL, Qu XW, Guo HT, et al. Novel Imino Sugar Derivatives Demonstrate Potent Antiviral Activity against Flaviviruses ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2009 APR; 53 (4): 1501-1508	1	7	14	34
1344	7141 Delaney WE, Locarnini S, Shaw T Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation ANTIVIRAL CHEMISTRY & CHEMOTHERAPY. 2001 JAN; 12 (1): 1-35	6	71	14	217
1345	7223 Block TM, Jordan R Iminosugars as possible broad spectrum anti hepatitis virus agents: the glucovirs and alkovirs ANTIVIRAL CHEMISTRY & CHEMOTHERAPY. 2001 NOV; 12 (6): 317-325	9	17	14	40
1346	6503 Terrault NA, Wright TL Therapy for chronic hepatitis B infection ANTIVIRAL CHEMOTHERAPY 4. 1996; 394: 189-205	0	5	4	128
1347	6100 SHEAD A, VICKERY K, PAJKOS A, MEDHURST R, FREIMAN J, et al. EFFECTS OF PHYLLANTHUS PLANT-EXTRACTS ON DUCK HEPATITIS-B VIRUS INVITRO AND INVIVO ANTIVIRAL RESEARCH. 1992 JUN; 18 (2): 127-138	22	27	7	36
1348	6193 YEH SF, HONG CY, HUANG YL, LIU TY, CHOO KB, et al. EFFECT OF AN EXTRACT FROM PHYLLANTHUS-AMARUS ON HEPATITIS-B SURFACE-ANTIGEN GENE-EXPRESSION IN HUMAN HEPATOMA-CELLS ANTIVIRAL RESEARCH. 1993 MAR; 20 (3): 185-192	22	34	8	21
1349	6194 MORALEDA G, WU TT, JILBERT AR, ALDRICH CE, CONDREAY LD, et al. INHIBITION OF DUCK HEPATITIS-B VIRUS-REPLICATION BY HYPERICIN ANTIVIRAL RESEARCH. 1993 MAR; 20 (3): 235-247	3	30	5	25
1350	6231 FERREA G, CANESSA A, SAMPIETRO F, CRUCIANI M, ROMUSSI G, et al. IN-VITRO ACTIVITY OF A COMBRETUM-MICRANTHUM EXTRACT AGAINST HERPES-SIMPLEX VIRUS TYPE-1 AND TYPE-2 ANTIVIRAL RESEARCH. 1993 AUG; 21 (4): 317-325	0	26	2	20
#	Date / Author / Journal	LCS	GCS	LCR	CR
1351	6296 JANSSEN HLA, KERHOFLOS CJ, HEIJTINK RA, SCHALM SW MEASUREMENT OF HBSAG TO MONITOR HEPATITIS-B VIRAL REPLICATION IN PATIENTS ON ALPHA-INTERFERON THERAPY ANTIVIRAL RESEARCH. 1994 APR; 23 (3-4): 251-257	3	14	2	13
1352	6431 CHEN HC, CHOU CK, LEE SD, WANG JC, YEH SF ACTIVE COMPOUNDS FROM SAUSSUREA-LAPPA CLARKS THAT SUPPRESS HEPATITIS-B VIRUS SURFACE-ANTIGEN GENE-EXPRESSION IN HUMAN HEPATOMA-CELLS ANTIVIRAL RESEARCH. 1995 MAY; 27 (1-2): 99-109	1	43	9	26
1353	6680 Chen HC, Chou CK, Sun CM, Yeh SF Suppressive effects of destruxin B on hepatitis B virus surface antigen gene expression in human hepatoma cells ANTIVIRAL RESEARCH. 1997 MAY; 34 (3): 137-144	0	16	4	28
1354	6991 Zoulim F Therapy of chronic hepatitis B virus infection: inhibition of the viral polymerase and other antiviral strategies ANTIVIRAL RESEARCH. 1999 NOV; 44 (1): 1-30	1	31	19	222
1355	7021 Korba BE, Cote P, Hornbuckle W, Schinazi R, Gerin JL, et al. Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks ANTIVIRAL RESEARCH. 2000 JAN; 45 (1): 19-32	7	27	3	38
1356	7224 Thursz M Genetic susceptibility in chronic viral hepatitis ANTIVIRAL RESEARCH. 2001 NOV; 52 (2): 113-116	5	30	3	20
1357	7322 Ouzounov S, Mehta A, Dwek RA, Block TM, Jordan R The combination of interferon alpha-2b and n-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: implications for hepatitis C virus (HCV) therapy ANTIVIRAL RESEARCH. 2002 SEP; 55 (3): 425-435	10	27	4	34
1358	7397 Notka F, Meier GR, Wagner R Inhibition of wild-type human immunodeficiency virus and reverse transcriptase inhibitor-resistant variants by Phyllanthus amarus ANTIVIRAL RESEARCH. 2003 APR; 58 (2): 175-186	6	21	11	55
1359	7439 Buckwold VE, Beer BE, Donis RO Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents ANTIVIRAL RESEARCH. 2003 SEP; 60 (1): 1-15	8	46	8	141
1360	7568 Zoulim F Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic Hepatitis B virus infection ANTIVIRAL RESEARCH. 2004 OCT; 64 (1): 1-15	4	79	21	143
#	Date / Author / Journal	LCS	GCS	LCR	CR
1361	7576 Notka F, Meier G, Wagner R Concerted inhibitory activities of Phyllanthus amarus on HIV replication in vitro and ex vivo ANTIVIRAL RESEARCH. 2004 NOV; 64 (2): 93-102	8	27	12	55
1362	7672 Shin MS, Kang EH, Lee YI A flavonoid from medicinal plants blocks hepatitis B virus-e antigen secretion in HBV-infected hepatocytes ANTIVIRAL RESEARCH. 2005 SEP; 67 (3): 163-168	4	27	6	18
1363	7752 Thimme R, Lohmann V, Weber F A target on the move: Innate and adaptive immune escape strategies of hepatitis C virus ANTIVIRAL RESEARCH. 2006 MAR; 69 (3): 129-141	1	46	5	196
1364	7801 Tan TMC, Chen Y, Kong KH, Bai J, Li Y, et al. Synthesis and the biological evaluation of 2-benzenesulfonylalkyl-5-substituted-sulfanyl-[1,3,4]-oxadiazoles as potential anti-hepatitis B virus agents ANTIVIRAL RESEARCH. 2006 AUG; 71 (1): 7-14	0	19	3	41
1365	7820 Tanaka Y, Kato J, Kohara M, Galinski MS Antiviral effects of glycosylation and glucose trimming inhibitors on human parainfluenza virus type 3 ANTIVIRAL RESEARCH. 2006 OCT; 72 (1): 1-9	2	10	7	26
1366	7840 Chi SW, Kim DH, Kim JS, Lee MK, Han KH Solution conformation of an immunodominant epitope in the hepatitis B virus preS2 surface antigen ANTIVIRAL RESEARCH. 2006 DEC; 72 (3): 207-215	1	1	5	49
1367	7992 Lazar C, Durantel D, Macovei A, Zitzmann N, Zoulim F, et al. Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity ANTIVIRAL RESEARCH. 2007 OCT; 76 (1): 30-37	4	10	16	34
1368	7993 StGelais C, Tuthill TJ, Clarke DS, Rowlands DJ, Harris M, et al. Inhibition of hepatitis C virus p7 membrane channels in a liposome-based assay system ANTIVIRAL RESEARCH. 2007 OCT; 76 (1): 48-58	14	18	11	48
1369	8004 Feld JJ, Colledge D, Sozzi V, Edwards R, Littlejohn M, et al. The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging ANTIVIRAL RESEARCH. 2007 NOV; 76 (2): 168-177	3	9	4	44
1370	8108 Xu J, Wang J, Deng F, Hu ZH, Wang HL Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro ANTIVIRAL RESEARCH. 2008 JUN; 78 (3): 242-249	0	8	2	42
#	Date / Author / Journal	LCS	GCS	LCR	CR
1371	8375 Luscombe CA, Huang ZH, Murray MG, Miller M, Wilkinson J, et al. A novel Hepatitis C virus p7 ion channel inhibitor, BIT225, inhibits bovine viral diarrhea virus in vitro and shows synergism with recombinant interferon-alpha-2b and nucleoside analogues ANTIVIRAL RESEARCH. 2010 MAY; 86 (2): 144-153	2	3	16	45
1372	7062 Korba BE, Cote P, Hornbuckle W, Schinazi R, Gangemi JD, et al. Enhanced antiviral benefit of combination therapy with lamivudine and alpha interferon against WHV replication in chronic carrier woodchucks ANTIVIRAL THERAPY. 2000 JUN; 5 (2): 95-104	4	20	5	38
1373	7398 Martin KW, Ernst E Antiviral agents from plants and herbs: a systematic review ANTIVIRAL THERAPY. 2003 APR; 8 (2): 77-90	4	29	9	71
1374	7714 Loomba R, Liang TJ Novel approaches to new therapies for hepatitis B virus infection ANTIVIRAL THERAPY. 2006; 11 (1): 1-15	2	14	4	121
1375	7715 Premkumar A, Dong XB, Haqshenas G, Gage PW, Gowans EJ Amantadine inhibits the function of an ion channel encoded by GB virus B, but fails to inhibit virus replication ANTIVIRAL THERAPY. 2006; 11 (3): 289-295	3	5	5	32
1376	7716 Mihm U, Grigorian N, Welsch C, Herrmann E, Kronenberger B, et al. Amino acid variations in hepatitis C virus p7 and sensitivity to antiviral combination therapy with amantadine in chronic hepatitis C ANTIVIRAL THERAPY. 2006; 11 (4): 507-519	5	10	6	47
1377	7860 Manesis EK, Hadziyannis ES, Angelopoulou OP, Hadziyannis SJ Prediction of treatment-related HBsAg loss in HBeAg-negative chronic hepatitis B: a clue from serum HBsAg levels ANTIVIRAL THERAPY. 2007; 12 (1): 73-82	2	32	4	36
1378	7861 Modi AA, Wright EC, Seeff LB Complementary and alternative medicine (CAM) for the treatment of chronic hepatitis B and C: a review ANTIVIRAL THERAPY. 2007; 12 (3): 285-295	0	6	8	101
1379	8035 Wiegand J, Wedemeyer H, Finger A, Heidrich B, Rosenau J, et al. A decline in hepatitis B virus surface antigen (HBsAg) predicts clearance, but does not correlate with quantitative HBeAg or HBV DNA levels ANTIVIRAL THERAPY. 2008; 13 (4): 547-554	1	9	3	38
1380	8175 Xiao F, Xiao Fan Dong F, Dong Fang Du B, Du Bin Li XY, Li Xueyong Cheng J, et al. Serum levels of surface large envelope proteins: prognostic markers for hepatitis B e antigen-negative patients with adefovir dipivoxil treatment ANTIVIRAL THERAPY. 2009; 14 (8): 1149-1156	0	0	3	28
#	Date / Author / Journal	LCS	GCS	LCR	CR
1381	8326 Liaw YF, Brunetto MR, Hadziyannis S The natural history of chronic HBV infection and geographical differences ANTIVIRAL THERAPY. 2010; 15: 25-33	0	0	3	80
1382	8327 Bonino F, Piratvisuth T, Brunetto MR, Liaw YF Diagnostic markers of chronic hepatitis B infection and disease ANTIVIRAL THERAPY. 2010; 15: 35-44	0	0	6	105
1383	8328 Kim HY, Eo EY, Park H, Kim YC, Park S, et al. Medicinal herbal extracts of Sophorae radix, Acanthopanacis cortex, Sanguisorbae radix and Torilis fructus inhibit coronavirus replication in vitro ANTIVIRAL THERAPY. 2010; 15 (5): 697-709	0	0	1	40
1384	4639 WILTERDINK JB NETHERLANDS-SOCIETY-FOR-MICROBIOLOGY, MEDICAL SECTION AND NETHERLANDS-ASSOCIATION-OF-LABORATORY-PHYSICIANS JOINT MEETING AT BILTHOVEN ON 28 APRIL 1983 - SYMPOSIUM ON VACCINATION AGAINST HEPATITIS-B - INTRODUCTION ANTONIE VAN LEEUWENHOEK JOURNAL OF MICROBIOLOGY. 1983; 49 (6): 597-598	0	0	1	2
1385	5468 ARYA SC, ASHRAF SJ, PARANDE CM, TOBEIQI MS, AGEEL AR HEPATITIS-B AND DELTA-MARKERS IN PRIMARY HEPATOCELLULAR-CARCINOMA PATIENTS IN THE GIZAN AREA OF SAUDI-ARABIA APMIS. 1988; 96: 30-34	0	0	6	20
1386	8229 Kalland KH, Ke XS, Oyan AM Tumour virology - history, status and future challenges APMIS. 2009 MAY-JUN; 117 (5-6): 382-399	0	0	4	165
1387	7601 Meadows PY, Bemis JE, Al-Maawali S, Walker GC Probing single polymer chain mechanics using atomic force microscopy APPLICATIONS OF SCANNED PROBE MICROSCOPY TO POLYMERS. 2005; 897: 148-161	0	1	1	25
1388	3150 LO S, GILBERT J, HETRICK F STABILITY OF HUMAN ENTEROVIRUSES IN ESTUARINE AND MARINE WATERS APPLIED AND ENVIRONMENTAL MICROBIOLOGY. 1976; 32 (2): 245-249	0	48	1	12
1389	1183 HOK KA, NIEMAN R, LACKEY JO, CABASSO VJ AUSTRALIA ANTIGEN IN A CLOSED ADULT POPULATION MONITORED FOR SERUM GLUTAMIC OXALACETIC TRANSAMINASE APPLIED MICROBIOLOGY. 1970; 20 (1): 6-&	10	14	13	18
1390	1455 HARTWELL WV, MAYNARD JE, BERQUIST KR SENSITIVE MATRIX GEL DIFFUSION TEST FOR DETECTION OF AUSTRALIA ANTIGEN APPLIED MICROBIOLOGY. 1971; 21 (4): 623-&	4	6	3	5
#	Date / Author / Journal	LCS	GCS	LCR	CR
1391	1456 CABASSO VJ, NIEMAN R, SCHROEDE.DD, HOK KA, LOUIE RE, et al. PREPARATION AND STANDARDIZATION OF AN AUSTRALIA ANTIGEN ANTIBODY OF EQUINE ORIGIN APPLIED MICROBIOLOGY. 1971; 21 (6): 1017-&	10	10	11	16
1392	1457 SCHMIDT NJ, GEE PS, LENNETTE EH RELATIVE SENSITIVITY OF GEL DIFFUSION, COMPLEMENT FIXATION, AND IMMUNOELECTROOSMOPHORESIS TESTS FOR DETECTION OF HEPATITIS-ASSOCIATED ANTIGEN AND ANTIBODY APPLIED MICROBIOLOGY. 1971; 22 (2): 165-&	12	24	11	16
1393	1814 KISSLING RE, BARKER LF EVALUATION OF ASSAY METHODS FOR HEPATITIS-ASSOCIATED ANTIGEN APPLIED MICROBIOLOGY. 1972; 23 (6): 1037-&	9	12	10	15
1394	2148 GERMAIN KH, STURDIVA.SK, RIGHTSEL WA EVALUATION OF A RED-CELL AGGLUTINATION TEST FOR DETECTION OF AUSTRALIA ANTIGEN (HB AG) APPLIED MICROBIOLOGY. 1973; 25 (4): 524-527	7	16	7	9
1395	2149 ROSENTHA.JD, HAYASHI K, NOTKINS AL COMPARISON OF DIRECT AND INDIRECT SOLID-PHASE MICRORADIOIMMUNOASSAYS FOR DETECTION OF VIRAL ANTIGENS AND ANTIVIRAL ANTIBODY APPLIED MICROBIOLOGY. 1973; 25 (4): 567-573	2	103	6	29
1396	2150 PETERSON DA, FROESNER GG, DEINHARD.FW EVALUATION OF PASSIVE HEMAGGLUTINATION, SOLID-PHASE RADIOIMMUNOASSAY, AND IMMUNOELECTROOSMOPHORESIS FOR DETECTION OF HEPATITIS-B ANTIGEN APPLIED MICROBIOLOGY. 1973; 26 (3): 376-380	8	23	13	18
1397	2151 PURCELL RH, WONG DC, ALTER HJ, HOLLAND PV MICROTITER SOLID-PHASE RADIOIMMUNOASSAY FOR HEPATITIS-B ANTIGEN APPLIED MICROBIOLOGY. 1973; 26 (4): 478-484	8	93	13	17
1398	2518 DAUGHART.H, YOUNG RG, HATCH MH, ZIEGLER DW INTERACTIONS OF STANDARD ANTIBODY WITH AUSTRALIA ANTIGENS IN AU AG-AB RADIOIMMUNOASSAY APPLIED MICROBIOLOGY. 1974; 27 (4): 756-762	3	4	13	23
1399	6332 RAVNDAL J, LOVOLD T, BENTSEN HB, ROED HK, GJEDREM T, et al. SERUM IRON LEVELS IN FARMED ATLANTIC SALMON - FAMILY VARIATION AND ASSOCIATIONS WITH DISEASE RESISTANCE AQUACULTURE. 1994 AUG; 125 (1-2): 37-45	0	15	5	23
1400	7908 Balasubramanian G, Sarathi M, Kumar SR, Hameed ASS Screening the antiviral activity of Indian medicinal plants against white spot syndrome virus in shrimp AQUACULTURE. 2007 MAR 6; 263 (1-4): 15-19	0	10	5	32

Date / Author / Journal

LCS

GCS

LCR

1301

4822 SHAFRITZ DA, LIEBERMAN HM

THE MOLECULAR-BIOLOGY OF HEPATITIS-B VIRUS

ANNUAL REVIEW OF MEDICINE. 1984; 35: 219-232

1302

6267 ROBINSON WS

MOLECULAR EVENTS IN THE PATHOGENESIS OF HEPADNAVIRUS-ASSOCIATED HEPATOCELLULAR-CARCINOMA

ANNUAL REVIEW OF MEDICINE. 1994; 45: 297-323

125

1303

221 ROSS JD, SYVERTON JT, TREADWELL PEJ

CULTURAL CHARACTERIZATION OF ANIMAL CELLS

ANNUAL REVIEW OF MICROBIOLOGY. 1962; 16: 141-&

408

1304

1454 SENCER DJ

EMERGING DISEASES OF MAN AND ANIMALS

ANNUAL REVIEW OF MICROBIOLOGY. 1971; 25: 465-&

117

1305

3403 ROBINSON WS

GENOME OF HEPATITIS-B VIRUS

ANNUAL REVIEW OF MICROBIOLOGY. 1977; 31: 357-377

1306

3840 PIKE RM

LABORATORY-ASSOCIATED INFECTIONS - INCIDENCE, FATALITIES, CAUSES, AND PREVENTION

ANNUAL REVIEW OF MICROBIOLOGY. 1979; 33: 41-66

197

1307

5894 SHERKER AH, MARION PL

HEPADNAVIRUSES AND HEPATOCELLULAR-CARCINOMA

ANNUAL REVIEW OF MICROBIOLOGY. 1991; 45: 475-508

191

1308

5614 FISHER EA, COATES PM, CORTNER JA

GENE POLYMORPHISMS AND VARIABILITY OF HUMAN APOLIPOPROTEINS

ANNUAL REVIEW OF NUTRITION. 1989; 9: 139-160

106

1309

6 DORFMAN A, MATHEWS MB

THE PHYSIOLOGY OF CONNECTIVE TISSUE

ANNUAL REVIEW OF PHYSIOLOGY. 1956; 18: 69-88

242

1310

90 MANWELL C

COMPARATIVE PHYSIOLOGY - BLOOD PIGMENTS

ANNUAL REVIEW OF PHYSIOLOGY. 1960; 22: 191-244

138

476

Date / Author / Journal

LCS

GCS

LCR

1311

1021 MAGNAN C, BENOIST J

BLOOD TYPE GROUPS OF FRENCH CANADIANS IN THE REGION OF SAGUENAY-LAC SAINT-JEAN

ANTHROPOLOGIE. 1969; 73 (1-2): 49-76

1312

4066 CORRAIN C, CAPITANIO M

HEMO-TYPOLOGICAL OBSERVATIONS ON KOULANGO (IVORY-COAST)

ANTHROPOLOGIE. 1980; 84 (3): 448-454

1313

8055 Mahal LK

Glycomics: Towards bioinformatic approaches to understanding glycosylation

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2008 JAN; 8 (1): 37-51

142

1314

4823 DIX D, COHEN P

THE INCIDENCE OF FEMALE CANCERS - CORRELATIONS WITH ETIOLOGIC IMPLICATIONS

ANTICANCER RESEARCH. 1984; 4 (3): 197-202

1315

5662 LIN TM, CHEN CJ, WU MM, YANG CS, CHEN JS, et al.

HEPATITIS-B VIRUS MARKERS IN CHINESE TWINS

ANTICANCER RESEARCH. 1989 MAY-JUN; 9 (3): 737-741

1316

6245 PASCALE RM, SIMILE MM, FEO F

GENOMIC ABNORMALITIES IN HEPATOCARCINOGENESIS - IMPLICATIONS FOR A CHEMOPREVENTIVE STRATEGY

ANTICANCER RESEARCH. 1993 SEP-OCT; 13 (5A): 1341-1356

191

1317

6441 ANGHILERI LJ

IRON, INTRACELLULAR CALCIUM-ION, LIPID-PEROXIDATION AND CARCINO-GENESIS

ANTICANCER RESEARCH. 1995 JUL-AUG; 15 (4): 1395-1400

1318

6702 Anghileri LJ, Thouvenot P

Non-transferrin-bound iron and tumor cells

ANTICANCER RESEARCH. 1997 JUL-AUG; 17 (4A): 2529-2533

1319

6785 Csatary LK, Telegdy L, Gergely P, Bodey B, Bakacs T

Preliminary report of a controlled trial of MTH-68/B (TM) virus vaccine treatment in acute B and C hepatitis: A phase II study

ANTICANCER RESEARCH. 1998 MAR-APR; 18 (2B): 1279-1282

1320

6885 Wang F, Elliott RL, Head JF

Inhibitory effect of deferoxamine mesylate and low iron diet on the 13762NF rat mammary adenocarcinoma

ANTICANCER RESEARCH. 1999 JAN-FEB; 19 (1A): 445-450

Date / Author / Journal

LCS

GCS

LCR

1321

6886 Csatary LK, Schnabel R, Bakacs T

Successful treatment of decompensated chronic viral hepatitis by bursal disease virus vaccine

ANTICANCER RESEARCH. 1999 JAN-FEB; 19 (1B): 629-633

1322

7085 Anghileri LJ, Plenat F, Labouyrie E, Thouvenot P

Iron-and aluminum-induced carcinogenesis

ANTICANCER RESEARCH. 2000 SEP-OCT; 20 (5A): 3007-3012

1323

7163 Fernandez-Pol JA, Hamilton PD, Klos DJ

Essential viral and cellular zinc and iron containing metalloproteins as targets for novel antiviral and anticancer agents: Implications for prevention and therapy of viral diseases and cancer

ANTICANCER RESEARCH. 2001 MAR-APR; 21 (2A): 931-957

176

1324

7340 Geier D, Hebert B, Potti A

Risk of primary non-hepatocellular malignancies in hereditary hemochromatosis

ANTICANCER RESEARCH. 2002 NOV-DEC; 22 (6B): 3797-3799

1325

7518 Yasumoto E, Nakano K, Nakayachi T, Morshed SRM, Hashimoto K, et al.

Cytotoxic activity of deferiprone, maltol and related hydroxyketones against human tumor cell lines

ANTICANCER RESEARCH. 2004 MAR-APR; 24 (2B): 755-762

1326

3149 DENES AE, EBERT JW, BERQUIST KR, MURPHY BL, MAYNARD JE

ANTIVIRAL EFFECTS OF VIRAZOLE IN CHRONIC HEPATITIS-B SURFACE ANTIGEN-SEROPOSITIVE CHIMPANZEES

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 1976; 10 (3): 571-572

1327

4824 HANTZ O, OOKA T, VITVITSKI L, PICHOUD C, TREPO C

COMPARISON OF PROPERTIES OF WOODCHUCK HEPATITIS-VIRUS AND HUMAN HEPATITIS-B VIRUS ENDOGENOUS DNA-POLYMERASES

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 1984; 25 (2): 242-246

1328

5772 FOUREL I, HANTZ O, WATANABE KA, JACQUET C, CHOMEL B, et al.

INHIBITORY EFFECTS OF 2'-FLUORINATED ARABINOSYL-PYRIMIDINE NUCLEOSIDES ON WOODCHUCK HEPATITIS-VIRUS REPLICATION IN CHRONICALLY INFECTED WOODCHUCKS

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 1990 MAR; 34 (3): 473-475

1329

5829 YOKOTA T, KONNO K, CHONAN E, MOCHIZUKI S, KOJIMA K, et al.

COMPARATIVE ACTIVITIES OF SEVERAL NUCLEOSIDE ANALOGS AGAINST DUCK HEPATITIS-B VIRUS INVITRO

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 1990 JUL; 34 (7): 1326-1330

1330

6731 Cullen JM, Smith SL, Davis MG, Dunn SE, Botteron C, et al.

In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1- [2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucks

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 1997 OCT; 41 (10): 2076-2082

Date / Author / Journal

LCS

GCS

LCR

1331

6732 Witcher JW, Boudinot FD, Baldwin BH, Ascenzi MA, Tennant BC, et al.

Pharmacokinetics of 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl) uracil in woodchucks

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 1997 OCT; 41 (10): 2184-2187

1332

6742 Hantz O, Borel C, Trabaud C, Zoulim F, Dessolin J, et al.

Selective inhibition of the duck hepatitis B virus by a new class of tetraazamacrocycles

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 1997 NOV; 41 (11): 2579-2581

1333

7346 Mehta A, Conyers B, Tyrrell DLJ, Walters KA, Tipples GA, et al.

Structure-activity relationship of a new class of anti-hepatitis B virus agents

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2002 DEC; 46 (12): 4004-4008

1334

7372 Stuyver LJ, Whitaker T, McBrayer TR, Hernandez-Santiago BI, Lostia S, et al.

Ribonucleoside analogue that blocks replication of bovine viral diarrhea and hepatitis C viruses in culture

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2003 JAN; 47 (1): 244-254

1335

7425 Givens MD, Dykstra CC, Brock KV, Stringfellow DA, Kumar A, et al.

Detection of inhibition of bovine viral diarrhea virus by aromatic cationic molecules

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2003 JUL; 47 (7): 2223-2230

1336

7426 Buckwold VE, Wei JY, Wenzel-Mathers M, Russell J

Synergistic in vitro interactions between alpha interferon and ribavirin against bovine viral diarrhea virus and yellow fever virus as surrogate models of hepatitis C virus replication

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2003 JUL; 47 (7): 2293-2298

1337

7501 Durantel D, Carrouee-Durantel S, Branza-Nichita N, Dwek RA, Zitzmann N

Effects of interferon, ribavirin, and iminosugar derivatives on cells persistently infected with noncytopathic bovine viral diarrhea virus

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2004 FEB; 48 (2): 497-504

1338

7538 Mehta AS, Gu BH, Conyers B, Ouzounov S, Wang LJ, et al.

alpha-galactosylceramide and novel synthetic glycolipids directly induce the innate host defense pathway and have direct activity against hepatitis B and C viruses

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2004 JUN; 48 (6): 2085-2090

1339

7539 Iyer RP, Roland A, Morrey JD, Mounir S, Korba B

Phosphorothioate di-and trinucleotides as a novel class of anti-hepatitis B virus agents

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2004 JUN; 48 (6): 2199-2205

1340

8011 Dougherty AM, Guo H, Westby G, Liu YJ, Simsek E, et al.

A substituted tetrahydro-tetrazolo-pyrimidine is a specific and novel inhibitor of hepatitis B virus surface antigen secretion

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2007 DEC; 51 (12): 4427-4437

Date / Author / Journal

LCS

GCS

LCR

1341

8099 Woodhouse SD, Smith C, Michelet M, Branza-Nichita N, Hussey M, et al.

Iminosugars in combination with interferon and ribavirin permanently eradicate noncytopathic bovine viral diarrhea virus from persistently infected cells

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2008 MAY; 52 (5): 1820-1828

1342

8117 Jenke ACW, Wilhelm AD, Orth V, Lipps HJ, Protzer U, et al.

Long-term suppression of hepatitis B virus replication by short hairpin RNA expression using the scaffold/matrix attachment region-based replicating vector system pEPI-1

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2008 JUL; 52 (7): 2355-2359

1343

8215 Chang JH, Wang LJ, Ma DL, Qu XW, Guo HT, et al.

Novel Imino Sugar Derivatives Demonstrate Potent Antiviral Activity against Flaviviruses

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2009 APR; 53 (4): 1501-1508

1344

7141 Delaney WE, Locarnini S, Shaw T

Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation

ANTIVIRAL CHEMISTRY & CHEMOTHERAPY. 2001 JAN; 12 (1): 1-35

217

1345

7223 Block TM, Jordan R

Iminosugars as possible broad spectrum anti hepatitis virus agents: the glucovirs and alkovirs

ANTIVIRAL CHEMISTRY & CHEMOTHERAPY. 2001 NOV; 12 (6): 317-325

1346

6503 Terrault NA, Wright TL

Therapy for chronic hepatitis B infection

ANTIVIRAL CHEMOTHERAPY 4. 1996; 394: 189-205

128

1347

6100 SHEAD A, VICKERY K, PAJKOS A, MEDHURST R, FREIMAN J, et al.

EFFECTS OF PHYLLANTHUS PLANT-EXTRACTS ON DUCK HEPATITIS-B VIRUS INVITRO AND INVIVO

ANTIVIRAL RESEARCH. 1992 JUN; 18 (2): 127-138

1348

6193 YEH SF, HONG CY, HUANG YL, LIU TY, CHOO KB, et al.

EFFECT OF AN EXTRACT FROM PHYLLANTHUS-AMARUS ON HEPATITIS-B SURFACE-ANTIGEN GENE-EXPRESSION IN HUMAN HEPATOMA-CELLS

ANTIVIRAL RESEARCH. 1993 MAR; 20 (3): 185-192

1349

6194 MORALEDA G, WU TT, JILBERT AR, ALDRICH CE, CONDREAY LD, et al.

INHIBITION OF DUCK HEPATITIS-B VIRUS-REPLICATION BY HYPERICIN

ANTIVIRAL RESEARCH. 1993 MAR; 20 (3): 235-247

1350

6231 FERREA G, CANESSA A, SAMPIETRO F, CRUCIANI M, ROMUSSI G, et al.

IN-VITRO ACTIVITY OF A COMBRETUM-MICRANTHUM EXTRACT AGAINST HERPES-SIMPLEX VIRUS TYPE-1 AND TYPE-2

ANTIVIRAL RESEARCH. 1993 AUG; 21 (4): 317-325

Date / Author / Journal

LCS

GCS

LCR

1351

6296 JANSSEN HLA, KERHOFLOS CJ, HEIJTINK RA, SCHALM SW

MEASUREMENT OF HBSAG TO MONITOR HEPATITIS-B VIRAL REPLICATION IN PATIENTS ON ALPHA-INTERFERON THERAPY

ANTIVIRAL RESEARCH. 1994 APR; 23 (3-4): 251-257

1352

6431 CHEN HC, CHOU CK, LEE SD, WANG JC, YEH SF

ACTIVE COMPOUNDS FROM SAUSSUREA-LAPPA CLARKS THAT SUPPRESS HEPATITIS-B VIRUS SURFACE-ANTIGEN GENE-EXPRESSION IN HUMAN HEPATOMA-CELLS

ANTIVIRAL RESEARCH. 1995 MAY; 27 (1-2): 99-109

1353

6680 Chen HC, Chou CK, Sun CM, Yeh SF

Suppressive effects of destruxin B on hepatitis B virus surface antigen gene expression in human hepatoma cells

ANTIVIRAL RESEARCH. 1997 MAY; 34 (3): 137-144

1354

6991 Zoulim F

Therapy of chronic hepatitis B virus infection: inhibition of the viral polymerase and other antiviral strategies

ANTIVIRAL RESEARCH. 1999 NOV; 44 (1): 1-30

222

1355

7021 Korba BE, Cote P, Hornbuckle W, Schinazi R, Gerin JL, et al.

Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks

ANTIVIRAL RESEARCH. 2000 JAN; 45 (1): 19-32

1356

7224 Thursz M

Genetic susceptibility in chronic viral hepatitis

ANTIVIRAL RESEARCH. 2001 NOV; 52 (2): 113-116

1357

7322 Ouzounov S, Mehta A, Dwek RA, Block TM, Jordan R

The combination of interferon alpha-2b and n-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: implications for hepatitis C virus (HCV) therapy

ANTIVIRAL RESEARCH. 2002 SEP; 55 (3): 425-435

1358

7397 Notka F, Meier GR, Wagner R

Inhibition of wild-type human immunodeficiency virus and reverse transcriptase inhibitor-resistant variants by Phyllanthus amarus

ANTIVIRAL RESEARCH. 2003 APR; 58 (2): 175-186

1359

7439 Buckwold VE, Beer BE, Donis RO

Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents

ANTIVIRAL RESEARCH. 2003 SEP; 60 (1): 1-15

141

1360

7568 Zoulim F

Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic Hepatitis B virus infection

ANTIVIRAL RESEARCH. 2004 OCT; 64 (1): 1-15

143

Date / Author / Journal

LCS

GCS

LCR

1361

7576 Notka F, Meier G, Wagner R

Concerted inhibitory activities of Phyllanthus amarus on HIV replication in vitro and ex vivo

ANTIVIRAL RESEARCH. 2004 NOV; 64 (2): 93-102

1362

7672 Shin MS, Kang EH, Lee YI

A flavonoid from medicinal plants blocks hepatitis B virus-e antigen secretion in HBV-infected hepatocytes

ANTIVIRAL RESEARCH. 2005 SEP; 67 (3): 163-168

1363

7752 Thimme R, Lohmann V, Weber F

A target on the move: Innate and adaptive immune escape strategies of hepatitis C virus

ANTIVIRAL RESEARCH. 2006 MAR; 69 (3): 129-141

196

1364

7801 Tan TMC, Chen Y, Kong KH, Bai J, Li Y, et al.

Synthesis and the biological evaluation of 2-benzenesulfonylalkyl-5-substituted-sulfanyl-[1,3,4]-oxadiazoles as potential anti-hepatitis B virus agents

ANTIVIRAL RESEARCH. 2006 AUG; 71 (1): 7-14

1365

7820 Tanaka Y, Kato J, Kohara M, Galinski MS

Antiviral effects of glycosylation and glucose trimming inhibitors on human parainfluenza virus type 3

ANTIVIRAL RESEARCH. 2006 OCT; 72 (1): 1-9

1366

7840 Chi SW, Kim DH, Kim JS, Lee MK, Han KH

Solution conformation of an immunodominant epitope in the hepatitis B virus preS2 surface antigen

ANTIVIRAL RESEARCH. 2006 DEC; 72 (3): 207-215

1367

7992 Lazar C, Durantel D, Macovei A, Zitzmann N, Zoulim F, et al.

Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity

ANTIVIRAL RESEARCH. 2007 OCT; 76 (1): 30-37

1368

7993 StGelais C, Tuthill TJ, Clarke DS, Rowlands DJ, Harris M, et al.

Inhibition of hepatitis C virus p7 membrane channels in a liposome-based assay system

ANTIVIRAL RESEARCH. 2007 OCT; 76 (1): 48-58

1369

8004 Feld JJ, Colledge D, Sozzi V, Edwards R, Littlejohn M, et al.

The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging

ANTIVIRAL RESEARCH. 2007 NOV; 76 (2): 168-177

1370

8108 Xu J, Wang J, Deng F, Hu ZH, Wang HL

Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro

ANTIVIRAL RESEARCH. 2008 JUN; 78 (3): 242-249

Date / Author / Journal

LCS

GCS

LCR

1371

8375 Luscombe CA, Huang ZH, Murray MG, Miller M, Wilkinson J, et al.

A novel Hepatitis C virus p7 ion channel inhibitor, BIT225, inhibits bovine viral diarrhea virus in vitro and shows synergism with recombinant interferon-alpha-2b and nucleoside analogues

ANTIVIRAL RESEARCH. 2010 MAY; 86 (2): 144-153

1372

7062 Korba BE, Cote P, Hornbuckle W, Schinazi R, Gangemi JD, et al.

Enhanced antiviral benefit of combination therapy with lamivudine and alpha interferon against WHV replication in chronic carrier woodchucks

ANTIVIRAL THERAPY. 2000 JUN; 5 (2): 95-104

1373

7398 Martin KW, Ernst E

Antiviral agents from plants and herbs: a systematic review

ANTIVIRAL THERAPY. 2003 APR; 8 (2): 77-90

1374

7714 Loomba R, Liang TJ

Novel approaches to new therapies for hepatitis B virus infection

ANTIVIRAL THERAPY. 2006; 11 (1): 1-15

121

1375

7715 Premkumar A, Dong XB, Haqshenas G, Gage PW, Gowans EJ

Amantadine inhibits the function of an ion channel encoded by GB virus B, but fails to inhibit virus replication

ANTIVIRAL THERAPY. 2006; 11 (3): 289-295

1376

7716 Mihm U, Grigorian N, Welsch C, Herrmann E, Kronenberger B, et al.

Amino acid variations in hepatitis C virus p7 and sensitivity to antiviral combination therapy with amantadine in chronic hepatitis C

ANTIVIRAL THERAPY. 2006; 11 (4): 507-519

1377

7860 Manesis EK, Hadziyannis ES, Angelopoulou OP, Hadziyannis SJ

Prediction of treatment-related HBsAg loss in HBeAg-negative chronic hepatitis B: a clue from serum HBsAg levels

ANTIVIRAL THERAPY. 2007; 12 (1): 73-82

1378

7861 Modi AA, Wright EC, Seeff LB

Complementary and alternative medicine (CAM) for the treatment of chronic hepatitis B and C: a review

ANTIVIRAL THERAPY. 2007; 12 (3): 285-295

101

1379

8035 Wiegand J, Wedemeyer H, Finger A, Heidrich B, Rosenau J, et al.

A decline in hepatitis B virus surface antigen (HBsAg) predicts clearance, but does not correlate with quantitative HBeAg or HBV DNA levels

ANTIVIRAL THERAPY. 2008; 13 (4): 547-554

1380

8175 Xiao F, Xiao Fan Dong F, Dong Fang Du B, Du Bin Li XY, Li Xueyong Cheng J, et al.

Serum levels of surface large envelope proteins: prognostic markers for hepatitis B e antigen-negative patients with adefovir dipivoxil treatment

ANTIVIRAL THERAPY. 2009; 14 (8): 1149-1156

Date / Author / Journal

LCS

GCS

LCR

1381

8326 Liaw YF, Brunetto MR, Hadziyannis S

The natural history of chronic HBV infection and geographical differences

ANTIVIRAL THERAPY. 2010; 15: 25-33

1382

8327 Bonino F, Piratvisuth T, Brunetto MR, Liaw YF

Diagnostic markers of chronic hepatitis B infection and disease

ANTIVIRAL THERAPY. 2010; 15: 35-44

105

1383

8328 Kim HY, Eo EY, Park H, Kim YC, Park S, et al.

Medicinal herbal extracts of Sophorae radix, Acanthopanacis cortex, Sanguisorbae radix and Torilis fructus inhibit coronavirus replication in vitro

ANTIVIRAL THERAPY. 2010; 15 (5): 697-709

1384

4639 WILTERDINK JB

NETHERLANDS-SOCIETY-FOR-MICROBIOLOGY, MEDICAL SECTION AND NETHERLANDS-ASSOCIATION-OF-LABORATORY-PHYSICIANS JOINT MEETING AT BILTHOVEN ON 28 APRIL 1983 - SYMPOSIUM ON VACCINATION AGAINST HEPATITIS-B - INTRODUCTION

ANTONIE VAN LEEUWENHOEK JOURNAL OF MICROBIOLOGY. 1983; 49 (6): 597-598

1385

5468 ARYA SC, ASHRAF SJ, PARANDE CM, TOBEIQI MS, AGEEL AR

HEPATITIS-B AND DELTA-MARKERS IN PRIMARY HEPATOCELLULAR-CARCINOMA PATIENTS IN THE GIZAN AREA OF SAUDI-ARABIA

APMIS. 1988; 96: 30-34

1386

8229 Kalland KH, Ke XS, Oyan AM

Tumour virology - history, status and future challenges

APMIS. 2009 MAY-JUN; 117 (5-6): 382-399

165

1387

7601 Meadows PY, Bemis JE, Al-Maawali S, Walker GC

Probing single polymer chain mechanics using atomic force microscopy

APPLICATIONS OF SCANNED PROBE MICROSCOPY TO POLYMERS. 2005; 897: 148-161

1388

3150 LO S, GILBERT J, HETRICK F

STABILITY OF HUMAN ENTEROVIRUSES IN ESTUARINE AND MARINE WATERS

APPLIED AND ENVIRONMENTAL MICROBIOLOGY. 1976; 32 (2): 245-249

1389

1183 HOK KA, NIEMAN R, LACKEY JO, CABASSO VJ

AUSTRALIA ANTIGEN IN A CLOSED ADULT POPULATION MONITORED FOR SERUM GLUTAMIC OXALACETIC TRANSAMINASE

APPLIED MICROBIOLOGY. 1970; 20 (1): 6-&

1390

1455 HARTWELL WV, MAYNARD JE, BERQUIST KR

SENSITIVE MATRIX GEL DIFFUSION TEST FOR DETECTION OF AUSTRALIA ANTIGEN

APPLIED MICROBIOLOGY. 1971; 21 (4): 623-&

Date / Author / Journal

LCS

GCS

LCR

1391

1456 CABASSO VJ, NIEMAN R, SCHROEDE.DD, HOK KA, LOUIE RE, et al.

PREPARATION AND STANDARDIZATION OF AN AUSTRALIA ANTIGEN ANTIBODY OF EQUINE ORIGIN

APPLIED MICROBIOLOGY. 1971; 21 (6): 1017-&

1392

1457 SCHMIDT NJ, GEE PS, LENNETTE EH

RELATIVE SENSITIVITY OF GEL DIFFUSION, COMPLEMENT FIXATION, AND IMMUNOELECTROOSMOPHORESIS TESTS FOR DETECTION OF HEPATITIS-ASSOCIATED ANTIGEN AND ANTIBODY

APPLIED MICROBIOLOGY. 1971; 22 (2): 165-&

1393

1814 KISSLING RE, BARKER LF

EVALUATION OF ASSAY METHODS FOR HEPATITIS-ASSOCIATED ANTIGEN

APPLIED MICROBIOLOGY. 1972; 23 (6): 1037-&

1394

2148 GERMAIN KH, STURDIVA.SK, RIGHTSEL WA

EVALUATION OF A RED-CELL AGGLUTINATION TEST FOR DETECTION OF AUSTRALIA ANTIGEN (HB AG)

APPLIED MICROBIOLOGY. 1973; 25 (4): 524-527

1395

2149 ROSENTHA.JD, HAYASHI K, NOTKINS AL

COMPARISON OF DIRECT AND INDIRECT SOLID-PHASE MICRORADIOIMMUNOASSAYS FOR DETECTION OF VIRAL ANTIGENS AND ANTIVIRAL ANTIBODY

APPLIED MICROBIOLOGY. 1973; 25 (4): 567-573

103

1396

2150 PETERSON DA, FROESNER GG, DEINHARD.FW

EVALUATION OF PASSIVE HEMAGGLUTINATION, SOLID-PHASE RADIOIMMUNOASSAY, AND IMMUNOELECTROOSMOPHORESIS FOR DETECTION OF HEPATITIS-B ANTIGEN

APPLIED MICROBIOLOGY. 1973; 26 (3): 376-380

1397

2151 PURCELL RH, WONG DC, ALTER HJ, HOLLAND PV

MICROTITER SOLID-PHASE RADIOIMMUNOASSAY FOR HEPATITIS-B ANTIGEN

APPLIED MICROBIOLOGY. 1973; 26 (4): 478-484

1398

2518 DAUGHART.H, YOUNG RG, HATCH MH, ZIEGLER DW

INTERACTIONS OF STANDARD ANTIBODY WITH AUSTRALIA ANTIGENS IN AU AG-AB RADIOIMMUNOASSAY

APPLIED MICROBIOLOGY. 1974; 27 (4): 756-762

1399

6332 RAVNDAL J, LOVOLD T, BENTSEN HB, ROED HK, GJEDREM T, et al.

SERUM IRON LEVELS IN FARMED ATLANTIC SALMON - FAMILY VARIATION AND ASSOCIATIONS WITH DISEASE RESISTANCE

AQUACULTURE. 1994 AUG; 125 (1-2): 37-45

1400

7908 Balasubramanian G, Sarathi M, Kumar SR, Hameed ASS

Screening the antiviral activity of Indian medicinal plants against white spot syndrome virus in shrimp

AQUACULTURE. 2007 MAR 6; 263 (1-4): 15-19

BS Blumberg Publications by BS Blumberg and the papers citing BS Blumberg	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 57415, GCS 264399, CR 412613 Collection span: 1954 - 2011
List of All Records